Collaborating Authors


AI can diagnose Osteoarthritis by analysing cartilage texture 3 years before it starts wearing away

Daily Mail - Science & tech

AI can be used to to determine whether someone will develop Osteoarthritis by analysing cartilage texture three years before it starts wearing away, study found. Researchers from John Hopkins Hospital and others ran an artificial intelligence model over scans of 86 people with no discernible symptoms of osteoarthritis. The machine learning model was about to detect the beginning stages of the condition with 78 per cent accuracy up to three years before symptom onset. In the UK about 8.5 million people have Osteoarthritis, a condition which causes joints to become painful and stiff - particularly in people over the age of 65. If the condition can be detected early a combination of weight loss and exercise could make Osteoarthritis less severe when it happens - or even delay onset.

How AI can Change the Future of Telemedicine


Artificial Intelligence and telemedicine are no more diverse. It has helped the digital health industry to emerge high from the scratch. This article outlines the various work areas of telemedicine and how Artificial Intelligence can change the life of healthcare systems even with challenges over the years. When in 1955, John McCarthy came up with the name "Artificial Intelligence" who had thought one day we would be diagnosing our health through the internet to distant locations? It was a dream by then, but not anymore.

Speech Processing for Disease - Prof. Ami Moyal, President, Afeka Tel Aviv College of Engineering - Voice Tech Podcast ep.076 - Voice Tech Podcast


Imagine if voice technology could be used to diagnose diseases! This could be a reality if voice tech is used to identify non-speech sounds, such as coughs. This focus is of particular interest at the moment as the world's governments rally resources to protect populations against COVID-19. This is one area of focus for this week's guest, Prof. Ami Moyal, President, Afeka Tel Aviv College of Engineering, Israel. Prof. Ami also talks about the future of voice technology and what we should be teaching children for them to be successful in the world.

Robot takes contact-free measurements of patients' vital signs


During the current coronavirus pandemic, one of the riskiest parts of a health care worker's job is assessing people who have symptoms of Covid-19. Researchers from MIT, Boston Dynamics, and Brigham and Women's Hospital hope to reduce that risk by using robots to remotely measure patients' vital signs. The robots, which are controlled by a handheld device, can also carry a tablet that allows doctors to ask patients about their symptoms without being in the same room. "In robotics, one of our goals is to use automation and robotic technology to remove people from dangerous jobs," says Henwei Huang, an MIT postdoc. "We thought it should be possible for us to use a robot to remove the health care worker from the risk of directly exposing themselves to the patient."

How AI & ML Contributing To Mobile App Development To Test COVID-19?


The pandemic coronavirus has taken the world by storm, with around 800 thousand deaths and 23 million cases, the situation is still not normal. The cases are increasing at a constant speed. Every country from developed to underdeveloped are working round the clock to find out its cure. But, now technologies like artificial intelligence and machine learning can save us from COVID-19. Our global researchers claim that the mobile app developed with these technologies could help test the coronavirus, and this news is not less than a ray of hope for us.

Who needs tests? This AI diagnoses Covid from your sex, age and address - ISRAEL21c


At the beginning of May, confident that the coronavirus curve was safely flattened, Israel sent its children back to school. Within weeks, more than 200 new Covid-19 cases were diagnosed in Jerusalem alone, linked to a single infected "super spreader" teacher who taught in several schools. As a new school year begins, Israel's capital city is trying various strategies to avoid a repeat of that public-health catastrophe. One solution it will use is a mathematical model that predicts -- with no physical testing or patient contact – who's likely to be infected and with what specific respiratory virus. "The idea is to mathematically model the way infectious diseases move in the community," explains EDAS Healthcare CEO Guy Livne. EDAS stands for Electronic Diagnosis And Surveillance.

Artificial Intelligence helps counter COVID-19 misinformation in – IAM Network


CAIRO: With most credible information on COVID-19 and its symptoms supplied in English, Arabic-speaking populations have faced a significant barrier, falling prey to hysterical and inaccurate social media posts that come from questionable sources. This urgent and potentially life-threatening problem was quickly identified by the team at DxWand, an Egyptian startup providing conversational artificial intelligence (AI) solutions -- and they sought a fast and effective fix for it. "In late February, we, as a team, were struggling to find credible information about COVID-19, and we found that one needs certain access to find credible information," said Ahmed Mahmoud, co-founder of DxWand. "That made us think about others who would find it challenging to make a distinction between credible and false information. Even on official websites it was sometimes hard to find an answer to a specific question. Or worse -- you would get your information from social media."

Screening for pancreatic cancer using artificial intelligence


Dr. Ananya Malhotra speaks to News-Medical about her latest research into pancreatic cancer, and how its prognosis could be improved by using artificial intelligence. The prognosis of several cancers, including pancreatic tumors, has hardly improved in the last decades, contrasting with a general dramatic increase in survival for most cancers. We felt that a new approach was required. Pancreatic cancer is a very rare disease (8-12 new cases diagnosed every year in a population of 100,000). Due to such a low incidence of this disease, screening the whole population is neither practical nor appropriate.

Researchers develop dog-like robot nurse to remotely measure patients' vital signs


Testing a patient for Covid-19 can be an unnerving experience for health care workers, but researchers from the Massachusetts Institute of Technology and Brigham and Women's Hospital in Boston are hoping to use robots to change that. Operating robots with a handheld device, medical workers may soon be able to talk with patients about their symptoms while measuring vitals -- all from another room. Researchers modified Boston Dynamics' dog-like robot spot to measure patients' vital signs. The researchers have been using a robot on healthy volunteers and are making plans to use it to test people who show Covid-19 symptoms in a hospital setting, the university said in a news release. "In robotics, one of our goals is to use automation and robotic technology to remove people from dangerous jobs," MIT postdoc Henwei Huang said, according to the release.

Boston Dynamics' Spot the robot dog remotely measuring patients' vitals amid coronavirus pandemic

Boston Herald

Spot the robot dog is ready to see you now for your contact-free vitals. Researchers from MIT and Brigham and Women's Hospital are exploring a new way to lower the risk for health-care workers amid the coronavirus pandemic -- by using Boston Dynamics' Spot the robot dog to remotely measure patients' vital signs. "In robotics, one of our goals is to use automation and robotic technology to remove people from dangerous jobs," Henwei Huang, an MIT postdoctoral researcher, said in a statement. "We thought it should be possible for us to use a robot to remove the health-care worker from the risk of directly exposing themselves to the patient." Using four cameras mounted on the dog-like robot, the researchers have shown that they can measure skin temperature, breathing rate, pulse rate and blood oxygen saturation in healthy patients.